THERABID

Mission Pharmacal Company

Application Filed: 2023-05-31

Trademark Application Details

Mark For: THERABID™ trademark registration is intended to cover the category of multivitamin preparations. [all]

Status

2023-06-10 UTC

LIVE APPLICATION Awaiting Examination

The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.

Research	OneLook Acronym Finder
Serial Number	98021734
Mark Literal Elements	THERABID
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	TRADEMARK
Register	PRINCIPAL
Current Location	NEW APPLICATION PROCESSING 2023-06-03
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	005: Adhesives 006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Pamela B. Huff
Attorney Docket Number	4825.017US7

Timeline

2023-05-31	Application Filed
2023-06-03	Location: NEW APPLICATION PROCESSING
2023-06-03	Status: Live/Pending
2023-06-03	Status: New application awaiting assignment to an examining attorney. See current trademark processing wait times for more information.
2023-06-03	Transaction Date

Trademark Parties (Applicants & Owners)

Party:	Mission Pharmacal Company
Address	10999 IH-10 West, Suite 1000 San Antonio, TEXAS UNITED STATES 78205
Legal Entity Type	Corporation
Legal Entity State	TEXAS

Documents

Application		2023-05-31
Drawing		2023-05-31

Attorney of Record

PAMELA B. HUFF
SCHWEGMAN LUNDBERG & WOESSNER P.A.
PO BOX 2938
MINNEAPOLIS, MN 55402

Good, Services, and Codes

IC 005. US 005 006 018 044 046 051 052. G & S: multivitamin preparations

International Codes:	5
U.S. Codes:	005,006,018,044,046,051,052

Type Code	Type
GS0051	multivitamin preparations

Trademark Filing History

Description	Date	Proceeding Number
NEW APPLICATION ENTERED	2023-06-03

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
THERABID 98021734 not registered Live/Pending	Mission Pharmacal Company 2023-05-31
THERABID 87045518 not registered Live/Pending	Mission Pharmacal Company 2016-05-20
THERABID 86115721 not registered Dead/Abandoned	MISSIONPHARMACAL COMPANY 2013-11-11
THERABID 85241342 not registered Dead/Abandoned	Mission Pharmacal Company 2011-02-14
THERABID 78411546 not registered Dead/Abandoned	MISSION PHARMACAL COMPANY 2004-04-30
THERABID 77528351 not registered Dead/Abandoned	Mission Pharmacal Company 2008-07-22
THERABID 72422097 0966889 Dead/Expired	MISSION PHARMACAL COMPANY 1972-04-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.